医学
随机对照试验
介绍
聊天机器人
临床试验
初级保健
医疗保健
家庭医学
替代医学
物理疗法
梅德林
考试(生物学)
远程医疗
卫生服务研究
随机化
研究设计
患者招募
护理部
医疗急救
持续时间(音乐)
初级卫生保健
治疗组和对照组
数据提取
重症监护医学
作者
Xinge Tao,Shuya Zhou,Kai Ding,Sairan Li,Yaneng Li,Boyou Wu,Qirui Huang,Wangyue Chen,Muzi Shen,En Meng,Xiaowang Chen,Hong Hu,Jinchao Zhang,Jie Zhou,Lei Zou,Libing Ma,Shasha Han
标识
DOI:10.1038/s41591-025-04176-7
摘要
Patient-facing large language models (LLMs) hold potential to streamline inefficient transitions from primary to specialist care. We developed the preassessment (PreA), an LLM chatbot co-designed with local stakeholders, to perform the general medical consultations for history-taking, preliminary diagnoses, and test ordering that would normally be performed by primary care providers and to generate referral reports for specialists. PreA was tested in a randomized controlled trial involving 111 specialists from 24 medical disciplines across two health centers, where 2,069 patients (1,141 women; 928 men) were randomly assigned to use PreA independently (PreA-only), use it with staff support (PreA-human), or not use it (No-PreA) before specialist consultation. The trial met its primary end points with the PreA-only group showing significantly reduced physician consultation duration (28.7% reduction; 3.14 ± 2.25 min) compared to the No-PreA group (4.41 ± 2.77 min; P < 0.001), alongside significant improvements in physician-perceived care coordination (mean scores 113.1% increase; 3.69 ± 0.90 versus 1.73 ± 0.95; P < 0.001) and patient-reported communication ease (mean scores 16.0% increase; 3.99 ± 0.62 versus 3.44 ± 0.97; P < 0.001). Equivalent outcomes between the PreA-only and PreA-human groups confirmed the autonomous operation capability. Co-designed PreA outperformed the same model with additional fine-tuning on local dialogues across clinical decision-making domains. Co-design with local stakeholders, compared to passive local data collecting, represents a more effective strategy for deploying LLMs to strengthen health systems and enhance patient-centered care in resource-limited settings. Chinese Clinical Trial Registry identifier: ChiCTR2400094159 .
科研通智能强力驱动
Strongly Powered by AbleSci AI